EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Trends in prescriptions and costs of psychotropic drugs in the UK from 2013 to 2023

Yu-Rou Tsai iD, Manuela De Allegri, Simona Di Folco, Stefan Kohler iD, Matthias Schwannauer, Ulrich Reininghaus iD, Hoa Thi Nguyen

BJPsych Open · 2026-11 · 12 (6)

DOI: 10.1192/bjo.2026.12141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BJPsych Open, online erschienen am 30.10.2026. Verfasst von Yu-Rou Tsai und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine and University Hospital, Heidelberg Institute of Global Health, Heidelberg University, Germany. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Understanding prescription trends and costs of psychotropic drugs is essential to inform mental healthcare policy and practice. However, comprehensive national evidence across psychotropic drug classes is limited, and little is known on how prescription volumes changed during the COVID-19 pandemic.

Aims

We examined prescription trends and costs of psychotropic drugs in the UK and assessed changes in prescription volumes following the onset of the COVID-19 pandemic.

Method

We analysed national Prescription Cost Analysis data from 2013 to 2023, for six major psychotropic drug classes. Annual prescription volumes, total costs and average costs per drug were estimated. Linear regression was used to assess temporal trends and changes in prescription volume during the pandemic years. Costs were adjusted for inflation to 2023 prices.

Results

Between 2013 and 2023, psychotropic prescriptions grew 4% (95% CI 3.9–4.2) annually. Prescriptions for antidepressants, antipsychotics, stimulants and anti-dementia drugs increased, but not for hypnotics and anxiolytics and drugs used in substance dependence. In contrast, total costs declined by approximately £328 million, and the average cost per drug dropped from £11 to £5.9. Prescription volume remained unchanged during the pandemic years, except for anti-dementia medications, which showed an annual reduction of 17.2% (95% CI 7.8–26.6) relative to the underlying temporal trend during the study period.

Conclusions

Our observed rising prescription trend is consistent with global evidence on availability and use of psychotropic drugs. Furthermore, we found a decrease both in total drug costs and average costs per drug.

Schlagwörter

Stichwörter der Autor:innen

Psychotropic drugsUKcostsprescriptionstrends

Autor:innen und Institutionen

  • Faculty of Medicine and University Hospital, Heidelberg Institute of Global Health, Heidelberg University, Germany.
  • School of Health in Social Science, The University of Edinburgh, UK.
  • Institute of Social Medicine, Epidemiology and Health Economics, Charité University Hospital Berlin, Berlin, Germany.
  • Department of Public Mental Health, Central Institute of Mental Health, Medical Faculty Mannheim, Heidelberg University, Germany.
  • Centre for Epidemiology and Public Health, Health Service and Population Research Department, Institute of Psychiatry, Psychology & Neuroscience, King's College London, UK.
  • German Centre for Mental Health, partner site Mannheim-Heidelberg-Ulm, Berlin, Germany.

ORCID-Profile: Yu-Rou Tsai, Stefan Kohler, Ulrich Reininghaus

Zitieren

APA

Tsai, Y. R., De Allegri, M., Di Folco, S., Kohler, S., Schwannauer, M., Reininghaus, U., & Nguyen, H. T. (2026). Trends in prescriptions and costs of psychotropic drugs in the UK from 2013 to 2023. BJPsych Open, 12(6). https://doi.org/10.1192/bjo.2026.12141

Vancouver

Tsai YR, De Allegri M, Di Folco S, Kohler S, Schwannauer M, Reininghaus U, et al. Trends in prescriptions and costs of psychotropic drugs in the UK from 2013 to 2023. BJPsych Open. 2026;12(6). doi:10.1192/bjo.2026.12141

BibTeX
@article{Tsai2026,
  author = {Tsai, Yu-Rou and De Allegri, Manuela and Di Folco, Simona and Kohler, Stefan and Schwannauer, Matthias and Reininghaus, Ulrich and Nguyen, Hoa Thi},
  title = {Trends in prescriptions and costs of psychotropic drugs in the UK from 2013 to 2023},
  journal = {BJPsych Open},
  year = {2026},
  volume = {12},
  number = {6},
  doi = {10.1192/bjo.2026.12141}
}
Kostenlos starten →